Table 1 Demographic and treatment characteristics of patients with SLE studied at the time of the onset sample
| Â | Model-A NP event | Matched controls for model-A NP events | Non-A, non-B NP events | Matched controls for non-A, non-B NP events |
|---|---|---|---|---|
Number of subjects | 26 | 52 | 190 | 380 |
Mean (SD) age | 34.4 (7.5) | 36.9 (10.9) | 33.3 (11.8) | 35.3 (11.5) |
Gender (female:male) | 21:5 | 42:10 | 177:13 | 353:27 |
Ethnicity | 9Â W, 6 A-C, 4 SA, 4 EA, 3Â H | 22Â W, 12 A-C, 4 SA, 7 EA, 6Â H, 1 other | 84Â W, 30 A-C, 4 SA, 41 EA, 18Â H, 13 other | 161Â W, 61 A-C, 13 SA, 81 EA, 36Â H, 26 other, 2 unknown |
Median dose of corticosteroids (mg) | 10 | 0.25 | 7.5 | 5 |
Number (%) taking anti-malarials | 16 (61) | 22 (42) | 140 (74) | 222 (58) |
Number (%) taking immunosuppressant drugs | 13 (50) | 10 (19) | 71 (37) | 144 (38) |